Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DUPILUMAB vs DUVELISIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DUPILUMAB vs DUVELISIB: Safety Overview

Metric DUPILUMAB DUVELISIB
Total FAERS Reports 379,249 757
Deaths Reported 1,536 165
Death Rate 0.4% 21.8%
Hospitalizations 17,008 282
Average Patient Age 44.7 yrs 64.7 yrs
% Female Patients 61.2% 40.0%
FDA Approval Date N/A Sep 24, 2018
Manufacturer sanofi-aventis U.S. LLC Secura Bio, Inc
Route SUBCUTANEOUS ORAL
Marketing Status Prescription Prescription